Please login to the form below

Not currently logged in
Email:
Password:

type 2 diabetes

This page shows the latest type 2 diabetes news and features for those working in and with pharma, biotech and healthcare.

AZ’s Farxiga cuts risk of death in chronic kidney disease

AZ’s Farxiga cuts risk of death in chronic kidney disease

the risk of hospitalisation for heart failure and nephropathy in type 2 diabetes,” he added. ... 39% in adults with type 2 diabetes and established cardiovascular disease compared with placebo.

Latest news

More from news
Approximately 33 fully matching, plus 455 partially matching documents found.

Latest Intelligence

  • Cortellis Drugs to Watch in 2020 report Cortellis Drugs to Watch in 2020 report

    list.The list focuses on the treatment and possible cure for chronic, progressive and often debilitating diseases and conditions, including breast cancer, multiple sclerosis (MS), type 2 diabetes, haemophilia and migraine. ... Rybelsus is available in

  • Leading AstraZeneca’s return to growth in Europe Leading AstraZeneca’s return to growth in Europe

    This is the first large real-world evidence study of its kind, evaluating the risk of hospitalisation for heart failure and death from any cause in patients with type 2 diabetes ... The drug has so far gained approval for use in patients with germline

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    to reverse type 2 diabetes in patients. ... The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease.

  • Deal Watch October 2018

    Novartis. Deal Type. Deal with. Details. Value. Acquisition. Endocyte. Portfolio of products and technology for. ... Suliqua &Lyxumia/ Adlyxin for Type 2 diabetes. Purchase of. royalty rights.

  • Quality in Care Diabetes 2018: the best in innovative diabetes care Quality in Care Diabetes 2018: the best in innovative diabetes care

    Now in its eighth year, QiC Diabetes rewards initiatives undertaken in the UK and Ireland to improve outcomes and quality of life for people living with diabetes – spanning people with type ... 1 and type 2 diabetes, and adults’ and children’s

More from intelligence
Approximately 5 fully matching, plus 41 partially matching documents found.

Latest appointments

  • Roche’s Torsten Hoffmann to join Zealand Pharma Roche’s Torsten Hoffmann to join Zealand Pharma

    In his new role at Zealand, Dr Hoffmann joins a more compact company focused on the discovery of drugs in cardio-metabolic diseases, diabetes and obesity. ... Its lead product is the GLP-1 agonist lixisenatide, which is licensed to Sanofi who markets it

  • bmore creative hires Kush Rach as new business director bmore creative hires Kush Rach as new business director

    He was a key account manager at the pharma company, where he worked in the diabetes therapeutic area, and was involved in the UK launch of Galvus (vildagliptin) for type 2 ... diabetes. Ben Blackmore, bmore creative's MD, told The Directory: "We are

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 22 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
90TEN

90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...

Latest intelligence

InSite Mapping™ - a Novel Tool for Insight-gathering and Patient Journey Mapping
Learn how a client engaged 18 rheumatologist advisors over 6 months to create a patient journey map for SLE....
Alone we can do so little, together we can do so much
Collaboration is at the heart of successful patient engagement and effective healthcare provision. But in such a complex, nuanced network, true collaborations are rare. So how can we, as an...
7 important considerations for creating an inclusive clinical trial website
You might have noticed that all of us here at COUCH Health are big advocates for taking action to improve diversity and inclusion in the world of clinical research. ‘Taking...

Infographics